Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Precision Biosciences (DTIL) Treasury Shares (2018 - 2025)

Precision Biosciences (DTIL) has disclosed Treasury Shares for 8 consecutive years, with $952000.0 as the latest value for Q4 2025.

  • Quarterly Treasury Shares changed 0.0% to $952000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $952000.0 through Dec 2025, changed 0.0% year-over-year, with the annual reading at $952000.0 for FY2025, 0.0% changed from the prior year.
  • Treasury Shares for Q4 2025 was $1.6 million at Precision Biosciences, down from $1.6 million in the prior quarter.
  • The five-year high for Treasury Shares was $1.6 million in Q3 2025, with the low at $214857.0 in Q4 2023.
  • Average Treasury Shares over 3 years is $1.2 million, with a median of $1.3 million recorded in 2025.
  • Peak annual rise in Treasury Shares hit 0.0% in 2021, while the deepest fall reached 0.0% in 2021.
  • Over 5 years, Treasury Shares stood at $952000.0 in 2021, then changed by 0.0% to $952000.0 in 2022, then changed by 0.0% to $952000.0 in 2023, then changed by 0.0% to $952000.0 in 2024, then changed by 0.0% to $952000.0 in 2025.
  • According to Business Quant data, Treasury Shares over the past three periods came in at $952000.0, $952000.0, and $952000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.